Tags: Chemical Compound, Chemical Substance.

Cenicriviroc (TAK-652 TBR-652) is an experimental drug candidate for the treatment of HIV infection. It is being developed by Takeda Pharmaceutical and Tobira Therapeutics. Cenicriviroc is an inhibitor of CCR2 and CCR5 receptors allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell.

Cenicriviroc.svg
IUPAC name
(SE)-8-(4-(2-Butoxyethoxy)phenyl)-1-isobutyl-N-(4-(((1-propyl-1H-imidazol-5-yl)methyl)sulfinyl)phenyl)-1234-tetrahydrobenzo[b]azocine-5-carboxamide

Loading...

This page contains content from the copyrighted Wikipedia article "Cenicriviroc"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.